Filtered By:
Source: The Journal of Thoracic and Cardiovascular Surgery
Procedure: Heart Valve Surgery

This page shows you your search results in order of date.

Order by Relevance | Date

Total 54 results found since Jan 2013.

Reply: Stentless versus stented bioprosthetic root replacement in the medicare population and the wisdom of crowds
In our recent analysis of long-term outcomes of aortic root operations in the United States among Medicare beneficiaries using the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS-ACSD) and Centers for Medicare and Medicaid Services linked data for patients aged 65 years or older undergoing elective aortic root surgery, we concluded that the bioprosthetic Bentall operation should be the procedure of choice in this population due to improved survival and lower stroke risk compared with the use of the mechanical Bentall, and lower risk of aortic valve reintervention compared with valve-sparing aortic root replacement.
Source: The Journal of Thoracic and Cardiovascular Surgery - April 21, 2023 Category: Cardiovascular & Thoracic Surgery Authors: G. Chad Hughes Tags: Letter to the Editor Source Type: research

Reply from the authors: Stentless versus stented bioprosthetic root replacement in the medicare population and the wisdom of crowds
In our recent analysis of long-term outcomes of aortic root operations in the United States among Medicare beneficiaries using the Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS-ACSD) and Centers for Medicare and Medicaid Services linked data for patients aged 65 years or older undergoing elective aortic root surgery, we concluded that the bioprosthetic Bentall operation should be the procedure of choice in this population due to improved survival and lower stroke risk compared with the use of the mechanical Bentall, and lower risk of aortic valve reintervention compared with valve-sparing aortic root replacement.
Source: The Journal of Thoracic and Cardiovascular Surgery - April 21, 2023 Category: Cardiovascular & Thoracic Surgery Authors: G. Chad Hughes Tags: Adult: Aorta: Letters to the Editor Source Type: research

Surgical Ablation for Atrial Fibrillation During Aortic and Mitral Valve Surgery: A Nationwide Population-Based Cohort Study
There is limited evidence on the effectiveness of surgical AF ablation in reducing mortality or thromboembolic events during aortic/mitral valve (AV/MV) surgery. We evaluated the association of surgical ablation vs. no-ablation with risks of all-cause death and ischemic stroke or systemic embolization (SE) among patients with preoperative atrial fibrillation (AF) undergoing concomitant AV or MV surgery.
Source: The Journal of Thoracic and Cardiovascular Surgery - September 9, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Ho Jin Kim, Ye-Jee Kim, Minju Kim, Jae Suk Yoo, Dae-Hee Kim, Duk-Woo Park, Sung-Ho Jung, Suk Jung Choo, Joon Bum Kim Source Type: research

The Impact of Perioperative Stroke and Delirium on Outcomes after Surgical Aortic Valve Replacement
The effects of stroke and delirium on post-discharge cognition and patient-centered health outcomes after surgical aortic valve replacement (SAVR) are not well characterized. Here we assess the impact of post-operative stroke and delirium on these health outcomes in SAVR patients at 90 days.
Source: The Journal of Thoracic and Cardiovascular Surgery - March 18, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Steven R. Mess é, Jessica R. Overbey, Vinod H. Thourani, Alan J. Moskowitz, Annetine C. Gelijns, Mark A. Groh, Michael J. Mack, Gorav Ailawadi, Karen L. Furie, Andrew M. Southerland, Michael L. James, Claudia Scala Moy, Lopa Gupta, Pierre Voisine, Louis Source Type: research

Commentary: Short-term pain, long-term gain with left ventricular function after mitral valve repair
Mitral regurgitation is a common disorder with serious consequences for patient morbidity, including arrhythmias, heart failure, and stroke, as well as mortality.1 For acceptable-risk patients with severe, symptomatic disease or evidence of left ventricular (LV) dysfunction, surgical repair at a center of excellence is widely accepted as the gold standard therapy2; however, no formal recommendations for optimal repair strategies exist, likely due to the multiple and complex phenotyping of primary mitral valve disease.
Source: The Journal of Thoracic and Cardiovascular Surgery - September 15, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Clancy W. Mullan, Arnar Geirsson Tags: Commentary Source Type: research

Commentary: Direct oral anticoagulants in heart surgery: A  question in need of an answer
The Invited Expert Opinion by Drs Kapadia and Svensson1 is focused on an important clinical challenge of whether direct oral anticoagulants (DOACs) can be used in patients with bioprosthetic valves who have atrial fibrillation (AF). Recommendations for anticoagulation therapy should focus on potential risks of early postoperative bleeding with DOAC treatment and not only on its long-term superiority over vitamin K antagonists (VKAs) for stroke prevention in patients with AF, with or without a bioprosthetic valve.
Source: The Journal of Thoracic and Cardiovascular Surgery - June 10, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Stephen D. Waterford, Niv Ad Tags: Commentary Source Type: research

Commentary: Direct oral anticoagulants in heart surgery: A  question in need of an answer
The Invited Expert Opinion by Drs Kapadia and Svensson1 is focused on an important clinical challenge of whether direct oral anticoagulants (DOACs) can be used in patients with bioprosthetic valves who have atrial fibrillation (AF). Recommendations for anticoagulation therapy should focus on potential risks of early postoperative bleeding with DOAC treatment and not only on its long-term superiority over vitamin K antagonists (VKAs) for stroke prevention in patients with AF, with or without a bioprosthetic valve.
Source: The Journal of Thoracic and Cardiovascular Surgery - June 10, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Stephen D. Waterford, Niv Ad Tags: Commentary Source Type: research

Commentary: Mid-term outcomes in a real-world transcatheter aortic valve replacement population
In this edition of the Journal, Percy and colleagues1 present a series of 866 patients who underwent transfemoral transcatheter aortic valve replacement (TAVR) at Brigham and Women's Hospital between 2011 and 2018. The authors compared 5-year survival in patients with and without periprocedural complications. The complications of interest were periprocedural stroke, paravalvular leak (PVL), new left bundle branch block, and permanent pacemaker (PPM) implantation. These complications appear to occur more frequently after TAVR than surgical aortic valve replacement (SAVR) in some randomized trials.
Source: The Journal of Thoracic and Cardiovascular Surgery - May 14, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Rachel Eikelboom, Aaron J. Spooner, Michael H. Yamashita Tags: Commentary Source Type: research

Commentary: In the era of mitral valve-in-valve therapy, mechanical prosthesis in young patients does not deserve to be forgotten
Chen and colleagues1 from Memorial Hospital of Taoyaun in Taiwan analyzed, retrospectively, the results of patients who received either biological or mechanical valve for mitral valve replacement in rheumatic heart disease. Patient data were extracted from the National Health Insurance administrative database in Taiwan. Propensity score analysis yielded 2 paired groups of 788 patients. No significant difference in terms of in-hospital mortality were observed between the 2 matched groups. Regarding late outcomes, all-cause mortality at 10  years was in favor of the mechanical valve group, risk of stroke tended to be higher...
Source: The Journal of Thoracic and Cardiovascular Surgery - April 1, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Francesco Formica, Francesco Maestri, Francesco Nicolini Tags: Commentary Source Type: research

Biological versus Mechanical Prostheses for Aortic Valve Replacement.
The objective was to compare long-term survival and major adverse cardiac and cardiovascular events (i.e. stroke, reoperation, and major bleeding) within this population.
Source: The Journal of Thoracic and Cardiovascular Surgery - February 5, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Emiliano A. Rodr íguez-Caulo, Oscar Blanco-Herrera, Elisabet Berastegui, Javier Arias-Dachary, Souhayla Souaf, Gertrudis Parody, Gregorio Laguna, SPAVALVE study group Source Type: research

Biological versus mechanical prostheses for aortic valve replacement
The objective was to compare long-term survival and major adverse cardiac and cardiovascular events (ie, stroke, reoperation, and major bleeding) within this population.
Source: The Journal of Thoracic and Cardiovascular Surgery - February 5, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Emiliano A. Rodr íguez-Caulo, Oscar R. Blanco-Herrera, Elisabet Berastegui, Javier Arias-Dachary, Souhayla Souaf-Khalafi, Gertrudis Parody-Cuerda, Gregorio Laguna, SPAVALVE Study Group Tags: Adult Source Type: research

Commentary: Expanding the utility of the Ross procedure —Proceed with caution
Clinical equipoise remains regarding the Ross procedure and its utility. The choice of conduit for aortic valve replacement in adults continues to represent a significant challenge for some clinicians and must be carefully tailored to each individual patient.1 The ideal valve procedure should carry a low incidence of stroke and other valve-related complications and be durable, reliable, anticoagulation-free, and fairly reproducible by a wide array of young and experienced surgeons. Continued technical improvements to the Ross procedure have expanded its indications over the past 2  decades, making it a viable option in older patients.
Source: The Journal of Thoracic and Cardiovascular Surgery - October 22, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Ramsey S. Elsayed, Craig J. Baker, Vaughn A. Starnes Tags: Commentary Source Type: research

Commentary: Expanding the utility of the Ross procedure —Proceed with caution
Clinical equipoise remains regarding the Ross procedure and its utility. The choice of conduit for aortic valve replacement in adults continues to represent a significant challenge for some clinicians and must be carefully tailored to each individual patient.1 The ideal valve procedure should carry a low incidence of stroke and other valve-related complications and be durable, reliable, anticoagulation-free, and fairly reproducible by a wide array of young and experienced surgeons. Continued technical improvements to the Ross procedure have expanded its indications over the past 2  decades, making it a viable option in older patients.
Source: The Journal of Thoracic and Cardiovascular Surgery - October 22, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Ramsey S. Elsayed, Craig J. Baker, Vaughn A. Starnes Tags: Commentary Source Type: research

Commentary: Transcending acceptable, moving toward optimal: Standardizing surgical configurations of ventricular assist device therapy
The number of patients with end-stage heart failure potentially eligible for ventricular assist device (VAD) therapy continues to increase.1 Meanwhile, VAD outcomes with current centrifugal devices have improved significantly and in the first few years after implantation are approaching those of transplantation, yet at the same time they remain encumbered by adverse events such as stroke and hemodynamic complications like aortic regurgitation (AR).2 Our understanding of the mechanisms of VAD complications has expanded from basic engineering of the devices themselves to the patient −pump interface (comorbidities, thrombog...
Source: The Journal of Thoracic and Cardiovascular Surgery - May 13, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Song Li, Daniel Zimpfer, Claudius Mahr Tags: Commentary Source Type: research

Commentary: Postpericardial syndrome after cardiac surgery: Is it really benign?
Lehto and colleagues1 report on the long-term outcomes of postpericardiotomy syndrome (PPS) occurring after aortic valve replacement (AVR) surgery. The patient cohort was drawn from 2 large Finnish multi-institutional clinical trial databases, namely CAREAVR (Consortium of Studies in the Field of Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Valve Replacement) and CAREBANK (Cardiovascular Research Consortium---A Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients),1 in which a total of 671 AVR patients (bioprosthesis, n  = 361 and mecha...
Source: The Journal of Thoracic and Cardiovascular Surgery - March 11, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Suk Jung Choo Tags: Commentary Source Type: research